ID

DB08960||

名称

Hexamethonium

描述

A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

cas号

60-26-4

唯一标识码

3C9PSP36Z2

状态

solid

组

experimental,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as hexamethonium compounds. These are organic compounds containing a N,N,N,N',N',N'-hexamethylhexane-1,6-diaminium moiety.
direct-parent:Hexamethonium compounds
kingdom:Organic compounds
superclass:Organic nitrogen compounds
class:Organonitrogen compounds
subclass:Quaternary ammonium salts
alternative-parent:Amines
alternative-parent:Hydrocarbon derivatives
alternative-parent:Organic cations
alternative-parent:Organic salts
alternative-parent:Organopnictogen compounds
alternative-parent:Tetraalkylammonium salts
substituent:Aliphatic acyclic compound
substituent:Amine
substituent:Hexamethonium
substituent:Hydrocarbon derivative
substituent:Organic cation
substituent:Organic salt
substituent:Organopnictogen compound
substituent:Tetraalkylammonium salt

消除途径

种类

Amines
D000588
Ammonium Compounds
D064751
Anticholinergic Agents
D018680
Antihypertensive Agents
D000959
Autonomic Agents
D001337
Bis-Trimethylammonium Compounds
D008725
Cardiovascular Agents
D002317
Central Nervous System Depressants
D002492
Cholinergic Agents
D018678
Ganglion Blockers
D005730
Hexamethonium Compounds
D006584
Muscle Relaxants

Muscle Relaxants, Peripherally Acting Agents

Neurotransmitter Agents
D018377
Nicotinic Antagonists
D018733
Nitrogen Compounds
D017672
Onium Compounds
D009861
Peripheral Nervous System Agents
D018373
Quaternary Ammonium Compounds
D000644

盐类

DBSALT001082Hexamethonium Bromide8J77X3S60355-97-0FAPSXSAPXXJTOU-UHFFFAOYSA-L362.194360.077575

蛋白质结合

清除

同义词

language:english; code:iupac; name;N,N,N,N',N',N'-hexamethylhexane-1,6-diaminium

国际品牌

BistriumBristol-Myers Squibb

配送量

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB00346
Alfuzosin may increase the hypotensive activities of Hexamethonium.
DB01143
Hexamethonium may increase the hypotensive activities of Amifostine.
DB01119
Diazoxide may increase the hypotensive activities of Hexamethonium.
DB00422
Methylphenidate may decrease the antihypertensive activities of Hexamethonium.
DB06701
Dexmethylphenidate may decrease the antihypertensive activities of Hexamethonium.
DB08935
Hexamethonium may increase the hypotensive activities of Obinutuzumab.
DB00806
Pentoxifylline may increase the hypotensive activities of Hexamethonium.
DB00073
Hexamethonium may increase the hypotensive activities of Rituximab.
DB00035
Desmopressin may decrease the antihypertensive activities of Hexamethonium.
DB00191
Phentermine may decrease the antihypertensive activities of Hexamethonium.
DB00211
Midodrine may decrease the antihypertensive activities of Hexamethonium.
DB00221
Isoetharine may decrease the antihypertensive activities of Hexamethonium.
DB00353
Methylergometrine may decrease the antihypertensive activities of Hexamethonium.
DB00368
Norepinephrine may decrease the antihypertensive activities of Hexamethonium.
DB00388
Phenylephrine may decrease the antihypertensive activities of Hexamethonium.
DB00397
Phenylpropanolamine may decrease the antihypertensive activities of Hexamethonium.
DB00490
Buspirone may decrease the antihypertensive activities of Hexamethonium.
DB00561
Doxapram may decrease the antihypertensive activities of Hexamethonium.
DB00610
Metaraminol may decrease the antihypertensive activities of Hexamethonium.
DB00668
Epinephrine may decrease the antihypertensive activities of Hexamethonium.
DB00699
Nicergoline may decrease the antihypertensive activities of Hexamethonium.
DB00723
Methoxamine may decrease the antihypertensive activities of Hexamethonium.
DB00816
Orciprenaline may decrease the antihypertensive activities of Hexamethonium.
DB00830
Phenmetrazine may decrease the antihypertensive activities of Hexamethonium.
DB00841
Dobutamine may decrease the antihypertensive activities of Hexamethonium.
DB00852
Pseudoephedrine may decrease the antihypertensive activities of Hexamethonium.
DB00867
Ritodrine may decrease the antihypertensive activities of Hexamethonium.
DB00901
Bitolterol may decrease the antihypertensive activities of Hexamethonium.
DB00935
Oxymetazoline may decrease the antihypertensive activities of Hexamethonium.
DB00938
Salmeterol may decrease the antihypertensive activities of Hexamethonium.
DB00983
Formoterol may decrease the antihypertensive activities of Hexamethonium.
DB00988
Dopamine may decrease the antihypertensive activities of Hexamethonium.
DB01001
Salbutamol may decrease the antihypertensive activities of Hexamethonium.
DB01064
Isoprenaline may decrease the antihypertensive activities of Hexamethonium.
DB01102
Arbutamine may decrease the antihypertensive activities of Hexamethonium.
DB01126
Dutasteride may decrease the antihypertensive activities of Hexamethonium.
DB01182
Propafenone may decrease the antihypertensive activities of Hexamethonium.
DB01216
Finasteride may decrease the antihypertensive activities of Hexamethonium.
DB01255
Lisdexamfetamine may decrease the antihypertensive activities of Hexamethonium.
DB01274
Arformoterol may decrease the antihypertensive activities of Hexamethonium.
DB01288
Fenoterol may decrease the antihypertensive activities of Hexamethonium.
DB01291
Pirbuterol may decrease the antihypertensive activities of Hexamethonium.
DB01363
Ephedra sinica root may decrease the antihypertensive activities of Hexamethonium.
DB01364
Ephedrine may decrease the antihypertensive activities of Hexamethonium.
DB01365
Mephentermine may decrease the antihypertensive activities of Hexamethonium.
DB01366
Procaterol may decrease the antihypertensive activities of Hexamethonium.
DB01407
Clenbuterol may decrease the antihypertensive activities of Hexamethonium.
DB01467
2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Hexamethonium.
DB01556
Chlorphentermine may decrease the antihypertensive activities of Hexamethonium.
DB01576
Dextroamphetamine may decrease the antihypertensive activities of Hexamethonium.
DB01579
Phendimetrazine may decrease the antihypertensive activities of Hexamethonium.
DB02032
Epicaptopril may decrease the antihypertensive activities of Hexamethonium.
DB04581
1-benzylimidazole may decrease the antihypertensive activities of Hexamethonium.
DB04855
Dronedarone may decrease the antihypertensive activities of Hexamethonium.
DB05039
Indacaterol may decrease the antihypertensive activities of Hexamethonium.
DB05395
Amibegron may decrease the antihypertensive activities of Hexamethonium.
DB06152
Nylidrin may decrease the antihypertensive activities of Hexamethonium.
DB06190
Solabegron may decrease the antihypertensive activities of Hexamethonium.
DB06262
Droxidopa may decrease the antihypertensive activities of Hexamethonium.
DB06694
Xylometazoline may decrease the antihypertensive activities of Hexamethonium.
DB06706
Isometheptene may decrease the antihypertensive activities of Hexamethonium.
DB06707
Levonordefrin may decrease the antihypertensive activities of Hexamethonium.
DB06711
Naphazoline may decrease the antihypertensive activities of Hexamethonium.
DB06763
Saralasin may decrease the antihypertensive activities of Hexamethonium.
DB06764
Tetryzoline may decrease the antihypertensive activities of Hexamethonium.
DB08841
Tyramine may decrease the antihypertensive activities of Hexamethonium.
DB08893
Mirabegron may decrease the antihypertensive activities of Hexamethonium.
DB08925
Adrafinil may decrease the antihypertensive activities of Hexamethonium.
DB08957
Hexoprenaline may decrease the antihypertensive activities of Hexamethonium.
DB08985
Etilefrine may decrease the antihypertensive activities of Hexamethonium.
DB09080
Olodaterol may decrease the antihypertensive activities of Hexamethonium.
DB09082
Vilanterol may decrease the antihypertensive activities of Hexamethonium.
DB09202
Cirazoline may decrease the antihypertensive activities of Hexamethonium.
DB09203
Synephrine may decrease the antihypertensive activities of Hexamethonium.
DB09205
Moxisylyte may decrease the antihypertensive activities of Hexamethonium.
DB09480
Iofetamine I-123 may decrease the antihypertensive activities of Hexamethonium.
DB11124
Racepinephrine may decrease the antihypertensive activities of Hexamethonium.
DB11273
Dihydroergocornine may decrease the antihypertensive activities of Hexamethonium.
DB11278
DL-Methylephedrine may decrease the antihypertensive activities of Hexamethonium.
DB11373
Amitraz may decrease the antihypertensive activities of Hexamethonium.
DB11481
Atipamezole may decrease the antihypertensive activities of Hexamethonium.
DB11541
Ractopamine may decrease the antihypertensive activities of Hexamethonium.
DB11587
Etafedrine may decrease the antihypertensive activities of Hexamethonium.
DB11785
Anisodamine may decrease the antihypertensive activities of Hexamethonium.
DB11871
PF-00610355 may decrease the antihypertensive activities of Hexamethonium.
DB12080
Ritobegron may decrease the antihypertensive activities of Hexamethonium.
DB12100
Abediterol may decrease the antihypertensive activities of Hexamethonium.
DB12248
Tulobuterol may decrease the antihypertensive activities of Hexamethonium.
DB12313
Dopexamine may decrease the antihypertensive activities of Hexamethonium.
DB12371
Siponimod may decrease the antihypertensive activities of Hexamethonium.
DB12551
Idazoxan may decrease the antihypertensive activities of Hexamethonium.
DB12779
Higenamine may decrease the antihypertensive activities of Hexamethonium.
DB12846
Reproterol may decrease the antihypertensive activities of Hexamethonium.
DB12927
Theodrenaline may decrease the antihypertensive activities of Hexamethonium.
DB13064
Tramazoline may decrease the antihypertensive activities of Hexamethonium.
DB13108
Mephedrone may decrease the antihypertensive activities of Hexamethonium.
DB13139
Levosalbutamol may decrease the antihypertensive activities of Hexamethonium.
DB13251
Octopamine may decrease the antihypertensive activities of Hexamethonium.
DB13341
Fenozolone may decrease the antihypertensive activities of Hexamethonium.
DB13345
Dihydroergocristine may decrease the antihypertensive activities of Hexamethonium.
DB13378
Norfenefrine may decrease the antihypertensive activities of Hexamethonium.
DB13385
Dihydroergocryptine may decrease the antihypertensive activities of Hexamethonium.
DB13398
Oxyfedrine may decrease the antihypertensive activities of Hexamethonium.
DB13399
Terguride may decrease the antihypertensive activities of Hexamethonium.
DB13453
Xenon may decrease the antihypertensive activities of Hexamethonium.
DB13510
Buflomedil may decrease the antihypertensive activities of Hexamethonium.
DB13559
Rimiterol may decrease the antihypertensive activities of Hexamethonium.
DB13624
Methoxyphenamine may decrease the antihypertensive activities of Hexamethonium.
DB13692
Tretoquinol may decrease the antihypertensive activities of Hexamethonium.
DB13703
Gepefrine may decrease the antihypertensive activities of Hexamethonium.
DB13777
Prenalterol may decrease the antihypertensive activities of Hexamethonium.
DB13781
Xamoterol may decrease the antihypertensive activities of Hexamethonium.
DB13852
Mefenorex may decrease the antihypertensive activities of Hexamethonium.
DB13917
Deoxyepinephrine may decrease the antihypertensive activities of Hexamethonium.
DB14231
Quinoline Yellow WS may decrease the antihypertensive activities of Hexamethonium.
DB00692
Phentolamine may decrease the antihypertensive activities of Hexamethonium.
DB00797
Tolazoline may decrease the antihypertensive activities of Hexamethonium.
DB00925
Phenoxybenzamine may decrease the antihypertensive activities of Hexamethonium.
DB08941
Isoxsuprine may decrease the antihypertensive activities of Hexamethonium.
DB08950
Indoramin may decrease the antihypertensive activities of Hexamethonium.
DB09242
Moxonidine may decrease the antihypertensive activities of Hexamethonium.
DB00945
Acetylsalicylic acid may decrease the antihypertensive activities of Hexamethonium.
DB15685
Selpercatinib may decrease the antihypertensive activities of Hexamethonium.
DB15965
Naxitamab may decrease the antihypertensive activities of Hexamethonium.
DB00921
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
DB00366
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00470
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00450
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00956
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
DB00557
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00653
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Magnesium sulfate.
DB01403
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
DB00765
Hexamethonium may increase the sedative activities of Metyrosine.
DB01017
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00370
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
DB00486
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB01173
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
DB09117
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
DB08883
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00413
Hexamethonium may increase the sedative activities of Pramipexole.
DB00268
Hexamethonium may increase the sedative activities of Ropinirole.
DB05271
Hexamethonium may increase the sedative activities of Rotigotine.
DB06201
The risk or severity of adverse effects can be increased when Rufinamide is combined with Hexamethonium.
DB09072
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB09034
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
DB06204
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB01041
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
DB00425
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
DB09527
The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Hexamethonium.
DB00214
The risk or severity of adverse effects can be increased when Torasemide is combined with Hexamethonium.
DB00263
The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Hexamethonium.
DB00310
The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Hexamethonium.
DB00311
The risk or severity of adverse effects can be increased when Ethoxzolamide is combined with Hexamethonium.
DB00359
The risk or severity of adverse effects can be increased when Sulfadiazine is combined with Hexamethonium.
DB00482
The risk or severity of adverse effects can be increased when Celecoxib is combined with Hexamethonium.
DB00524
The risk or severity of adverse effects can be increased when Metolazone is combined with Hexamethonium.
DB00559
The risk or severity of adverse effects can be increased when Bosentan is combined with Hexamethonium.
DB00576
The risk or severity of adverse effects can be increased when Sulfamethizole is combined with Hexamethonium.
DB00664
The risk or severity of adverse effects can be increased when Sulfametopyrazine is combined with Hexamethonium.
DB00669
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Hexamethonium.
DB00695
The risk or severity of adverse effects can be increased when Furosemide is combined with Hexamethonium.
DB00706
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Hexamethonium.
DB00795
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Hexamethonium.
DB00819
The risk or severity of adverse effects can be increased when Acetazolamide is combined with Hexamethonium.
DB00887
The risk or severity of adverse effects can be increased when Bumetanide is combined with Hexamethonium.
DB00891
The risk or severity of adverse effects can be increased when Sulfapyridine is combined with Hexamethonium.
DB00909
The risk or severity of adverse effects can be increased when Zonisamide is combined with Hexamethonium.
DB01015
The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Hexamethonium.
DB01032
The risk or severity of adverse effects can be increased when Probenecid is combined with Hexamethonium.
DB01098
The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Hexamethonium.
DB01144
The risk or severity of adverse effects can be increased when Diclofenamide is combined with Hexamethonium.
DB01264
The risk or severity of adverse effects can be increased when Darunavir is combined with Hexamethonium.
DB01298
The risk or severity of adverse effects can be increased when Sulfacytine is combined with Hexamethonium.
DB01299
The risk or severity of adverse effects can be increased when Sulfadoxine is combined with Hexamethonium.
DB01325
The risk or severity of adverse effects can be increased when Quinethazone is combined with Hexamethonium.
DB01382
The risk or severity of adverse effects can be increased when Glymidine is combined with Hexamethonium.
DB01581
The risk or severity of adverse effects can be increased when Sulfamerazine is combined with Hexamethonium.
DB01582
The risk or severity of adverse effects can be increased when Sulfamethazine is combined with Hexamethonium.
DB02925
The risk or severity of adverse effects can be increased when Piretanide is combined with Hexamethonium.
DB04707
The risk or severity of adverse effects can be increased when Hydroxyfasudil is combined with Hexamethonium.
DB06150
The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Hexamethonium.
DB06290
The risk or severity of adverse effects can be increased when Simeprevir is combined with Hexamethonium.
DB06729
The risk or severity of adverse effects can be increased when Sulfaphenazole is combined with Hexamethonium.
DB06821
The risk or severity of adverse effects can be increased when Sulfameter is combined with Hexamethonium.
DB07996
The risk or severity of adverse effects can be increased when 5-(2-methylpiperazine-1-sulfonyl)isoquinoline is combined with Hexamethonium.
DB08162
The risk or severity of adverse effects can be increased when Fasudil is combined with Hexamethonium.
DB08798
The risk or severity of adverse effects can be increased when Sulfamoxole is combined with Hexamethonium.
DB08881
The risk or severity of adverse effects can be increased when Vemurafenib is combined with Hexamethonium.
DB08961
The risk or severity of adverse effects can be increased when Azosemide is combined with Hexamethonium.
DB11389
The risk or severity of adverse effects can be increased when Clorsulon is combined with Hexamethonium.
DB11461
The risk or severity of adverse effects can be increased when Sulfachlorpyridazine is combined with Hexamethonium.
DB11462
The risk or severity of adverse effects can be increased when Sulfaethoxypyridazine is combined with Hexamethonium.
DB11463
The risk or severity of adverse effects can be increased when Sulfanitran is combined with Hexamethonium.
DB11464
The risk or severity of adverse effects can be increased when Sulfaquinoxaline is combined with Hexamethonium.
DB12051
The risk or severity of adverse effects can be increased when Setrobuvir is combined with Hexamethonium.
DB12921
The risk or severity of adverse effects can be increased when Chlorsulfaquinoxaline is combined with Hexamethonium.
DB13214
The risk or severity of adverse effects can be increased when Sulfadicramide is combined with Hexamethonium.
DB13248
The risk or severity of adverse effects can be increased when Phthalylsulfathiazole is combined with Hexamethonium.
DB13283
The risk or severity of adverse effects can be increased when Sulfaisodimidine is combined with Hexamethonium.
DB13284
The risk or severity of adverse effects can be increased when Meticrane is combined with Hexamethonium.
DB13320
The risk or severity of adverse effects can be increased when Sulfaperin is combined with Hexamethonium.
DB13405
The risk or severity of adverse effects can be increased when Mefruside is combined with Hexamethonium.
DB13485
The risk or severity of adverse effects can be increased when Sulfametomidine is combined with Hexamethonium.
DB13547
The risk or severity of adverse effects can be increased when Sulfatolamide is combined with Hexamethonium.
DB13556
The risk or severity of adverse effects can be increased when Sulfamazone is combined with Hexamethonium.
DB13580
The risk or severity of adverse effects can be increased when Succinylsulfathiazole is combined with Hexamethonium.
DB13617
The risk or severity of adverse effects can be increased when Clorexolone is combined with Hexamethonium.
DB13663
The risk or severity of adverse effects can be increased when Clofenamide is combined with Hexamethonium.
DB13699
The risk or severity of adverse effects can be increased when Sulfathiourea is combined with Hexamethonium.
DB13708
The risk or severity of adverse effects can be increased when Fenquizone is combined with Hexamethonium.
DB13726
The risk or severity of adverse effects can be increased when Sulfaguanidine is combined with Hexamethonium.
DB13773
The risk or severity of adverse effects can be increased when Sulfamethoxypyridazine is combined with Hexamethonium.
DB13792
The risk or severity of adverse effects can be increased when Clopamide is combined with Hexamethonium.
DB13803
The risk or severity of adverse effects can be increased when Xipamide is combined with Hexamethonium.
DB14033
The risk or severity of adverse effects can be increased when Acetyl sulfisoxazole is combined with Hexamethonium.
DB00703
The risk or severity of adverse effects can be increased when Methazolamide is combined with Hexamethonium.
DB06370
The risk or severity of adverse effects can be increased when Indisulam is combined with Hexamethonium.
DB00333
The risk or severity of adverse effects can be increased when Methadone is combined with Hexamethonium.
DB00083
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Botulinum toxin type A.
DB00042
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Botulinum Toxin Type B.
DB09282
Molsidomine may increase the hypotensive activities of Hexamethonium.
DB00212
Remikiren may increase the hypotensive activities of Hexamethonium.
DB00217
Bethanidine may increase the hypotensive activities of Hexamethonium.
DB00226
Guanadrel may increase the hypotensive activities of Hexamethonium.
DB00287
Travoprost may increase the hypotensive activities of Hexamethonium.
DB00521
Carteolol may increase the hypotensive activities of Hexamethonium.
DB00616
Candoxatril may increase the hypotensive activities of Hexamethonium.
DB00629
Guanabenz may increase the hypotensive activities of Hexamethonium.
DB00785
Cryptenamine may increase the hypotensive activities of Hexamethonium.
DB00869
Dorzolamide may increase the hypotensive activities of Hexamethonium.
DB00886
Omapatrilat may increase the hypotensive activities of Hexamethonium.
DB00905
Bimatoprost may increase the hypotensive activities of Hexamethonium.
DB01089
Deserpidine may increase the hypotensive activities of Hexamethonium.
DB01090
Pentolinium may increase the hypotensive activities of Hexamethonium.
DB01116
Trimethaphan may increase the hypotensive activities of Hexamethonium.
DB01170
Guanethidine may increase the hypotensive activities of Hexamethonium.
DB01180
Rescinnamine may increase the hypotensive activities of Hexamethonium.
DB01214
Metipranolol may increase the hypotensive activities of Hexamethonium.
DB01295
Bevantolol may increase the hypotensive activities of Hexamethonium.
DB01297
Practolol may increase the hypotensive activities of Hexamethonium.
DB01347
Saprisartan may increase the hypotensive activities of Hexamethonium.
DB01348
Spirapril may increase the hypotensive activities of Hexamethonium.
DB01388
Mibefradil may increase the hypotensive activities of Hexamethonium.
DB03322
Dexpropranolol may increase the hypotensive activities of Hexamethonium.
DB04831
Tienilic acid may increase the hypotensive activities of Hexamethonium.
DB04840
Debrisoquine may increase the hypotensive activities of Hexamethonium.
DB04846
Celiprolol may increase the hypotensive activities of Hexamethonium.
DB06268
Sitaxentan may increase the hypotensive activities of Hexamethonium.
DB06403
Ambrisentan may increase the hypotensive activities of Hexamethonium.
DB06445
Diethylnorspermine may increase the hypotensive activities of Hexamethonium.
DB06762
Pinacidil may increase the hypotensive activities of Hexamethonium.
DB06826
Unoprostone may increase the hypotensive activities of Hexamethonium.
DB07767
Ferulic acid may increase the hypotensive activities of Hexamethonium.
DB08808
Bupranolol may increase the hypotensive activities of Hexamethonium.
DB08836
Temocapril may increase the hypotensive activities of Hexamethonium.
DB08932
Macitentan may increase the hypotensive activities of Hexamethonium.
DB08952
Indenolol may increase the hypotensive activities of Hexamethonium.
DB09206
Hexamethonium may increase the hypotensive activities of Trimazosin.
DB09220
Hexamethonium may increase the hypotensive activities of Nicorandil.
DB09238
Hexamethonium may increase the hypotensive activities of Manidipine.
DB09239
Hexamethonium may increase the hypotensive activities of Niguldipine.
DB09363
Hexamethonium may increase the hypotensive activities of Rauwolfia serpentina root.
DB11362
Hexamethonium may increase the hypotensive activities of Selexipag.
DB11720
Hexamethonium may increase the hypotensive activities of Angiotensin 1-7.
DB11738
Hexamethonium may increase the hypotensive activities of Rilmenidine.
DB11770
Hexamethonium may increase the hypotensive activities of Talinolol.
DB12054
Hexamethonium may increase the hypotensive activities of BQ-123.
DB12092
Hexamethonium may increase the hypotensive activities of Naftopidil.
DB12212
Hexamethonium may increase the hypotensive activities of Landiolol.
DB12766
Hexamethonium may increase the hypotensive activities of Cicletanine.
DB12945
Hexamethonium may increase the hypotensive activities of Dihydralazine.
DB13166
Hexamethonium may increase the hypotensive activities of Zofenopril.
DB13211
Hexamethonium may increase the hypotensive activities of Guanoxan.
DB13312
Hexamethonium may increase the hypotensive activities of Delapril.
DB13374
Hexamethonium may increase the hypotensive activities of Vincamine.
DB13400
Hexamethonium may increase the hypotensive activities of Linsidomine.
DB13410
Hexamethonium may increase the hypotensive activities of Guanoxabenz.
DB13429
Hexamethonium may increase the hypotensive activities of Tolonidine.
DB13435
Hexamethonium may increase the hypotensive activities of Endralazine.
DB13443
Hexamethonium may increase the hypotensive activities of Esatenolol.
DB13452
Hexamethonium may increase the hypotensive activities of Cadralazine.
DB13508
Hexamethonium may increase the hypotensive activities of Cloranolol.
DB13575
Hexamethonium may increase the hypotensive activities of Bietaserpine.
DB13604
Hexamethonium may increase the hypotensive activities of Guanazodine.
DB13631
Hexamethonium may increase the hypotensive activities of Methoserpidine.
DB13757
Hexamethonium may increase the hypotensive activities of Epanolol.
DB13779
Hexamethonium may increase the hypotensive activities of Guanoclor.
DB13801
Hexamethonium may increase the hypotensive activities of Muzolimine.
DB13919
Hexamethonium may increase the hypotensive activities of Candesartan.
DB14068
Hexamethonium may increase the hypotensive activities of Dexniguldipine.
DB14094
Hexamethonium may increase the hypotensive activities of Tocopherylquinone.
DB14125
Hexamethonium may increase the hypotensive activities of Benazeprilat.
DB14207
Hexamethonium may increase the hypotensive activities of Fosinoprilat.
DB14208
Hexamethonium may increase the hypotensive activities of Ramiprilat.
DB14213
Hexamethonium may increase the hypotensive activities of Perindoprilat.
DB14217
Hexamethonium may increase the hypotensive activities of Quinaprilat.
DB00177
Valsartan may increase the hypotensive activities of Hexamethonium.
DB00187
Esmolol may increase the hypotensive activities of Hexamethonium.
DB00195
Betaxolol may increase the hypotensive activities of Hexamethonium.
DB00264
Metoprolol may increase the hypotensive activities of Hexamethonium.
DB00270
Isradipine may increase the hypotensive activities of Hexamethonium.
DB00275
Olmesartan may increase the hypotensive activities of Hexamethonium.
DB00325
Nitroprusside may increase the hypotensive activities of Hexamethonium.
DB00335
Atenolol may increase the hypotensive activities of Hexamethonium.
DB00343
Diltiazem may increase the hypotensive activities of Hexamethonium.
DB00350
Minoxidil may increase the hypotensive activities of Hexamethonium.
DB00373
Timolol may increase the hypotensive activities of Hexamethonium.
DB00381
Amlodipine may increase the hypotensive activities of Hexamethonium.
DB00393
Nimodipine may increase the hypotensive activities of Hexamethonium.
DB00401
Nisoldipine may increase the hypotensive activities of Hexamethonium.
DB00492
Fosinopril may increase the hypotensive activities of Hexamethonium.
DB00519
Trandolapril may increase the hypotensive activities of Hexamethonium.
DB00528
Lercanidipine may increase the hypotensive activities of Hexamethonium.
DB00542
Benazepril may increase the hypotensive activities of Hexamethonium.
DB00571
Propranolol may increase the hypotensive activities of Hexamethonium.
DB00584
Enalapril may increase the hypotensive activities of Hexamethonium.
DB00590
Doxazosin may increase the hypotensive activities of Hexamethonium.
DB00598
Labetalol may increase the hypotensive activities of Hexamethonium.
DB00612
Bisoprolol may increase the hypotensive activities of Hexamethonium.
DB00678
Losartan may increase the hypotensive activities of Hexamethonium.
DB00691
Moexipril may increase the hypotensive activities of Hexamethonium.
DB00700
Eplerenone may increase the hypotensive activities of Hexamethonium.
DB00722
Lisinopril may increase the hypotensive activities of Hexamethonium.
DB00727
Nitroglycerin may increase the hypotensive activities of Hexamethonium.
DB00796
Candesartan cilexetil may increase the hypotensive activities of Hexamethonium.
DB00800
Fenoldopam may increase the hypotensive activities of Hexamethonium.
DB00876
Eprosartan may increase the hypotensive activities of Hexamethonium.
DB00881
Quinapril may increase the hypotensive activities of Hexamethonium.
DB00966
Telmisartan may increase the hypotensive activities of Hexamethonium.
DB00968
Methyldopa may increase the hypotensive activities of Hexamethonium.
DB01023
Felodipine may increase the hypotensive activities of Hexamethonium.
DB01029
Irbesartan may increase the hypotensive activities of Hexamethonium.
DB01054
Nitrendipine may increase the hypotensive activities of Hexamethonium.
DB01136
Carvedilol may increase the hypotensive activities of Hexamethonium.
DB01158
Bretylium may increase the hypotensive activities of Hexamethonium.
DB01162
Terazosin may increase the hypotensive activities of Hexamethonium.
DB01193
Acebutolol may increase the hypotensive activities of Hexamethonium.
DB01197
Captopril may increase the hypotensive activities of Hexamethonium.
DB01203
Nadolol may increase the hypotensive activities of Hexamethonium.
DB01244
Bepridil may increase the hypotensive activities of Hexamethonium.
DB01275
Hydralazine may increase the hypotensive activities of Hexamethonium.
DB01340
Cilazapril may increase the hypotensive activities of Hexamethonium.
DB04861
Nebivolol may increase the hypotensive activities of Hexamethonium.
DB06712
Nilvadipine may increase the hypotensive activities of Hexamethonium.
DB08931
Riociguat may increase the hypotensive activities of Hexamethonium.
DB09026
Aliskiren may increase the hypotensive activities of Hexamethonium.
DB09235
Efonidipine may increase the hypotensive activities of Hexamethonium.
DB09236
Lacidipine may increase the hypotensive activities of Hexamethonium.
DB09477
Enalaprilat may increase the hypotensive activities of Hexamethonium.
DB11783
Imidapril may increase the hypotensive activities of Hexamethonium.
DB00178
Ramipril may increase the hypotensive activities of Hexamethonium.
DB00790
Perindopril may increase the hypotensive activities of Hexamethonium.
DB09237
Hexamethonium may increase the hypotensive activities of Levamlodipine.
DB00484
Brimonidine may increase the antihypertensive activities of Hexamethonium.
DB00898
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
DB00972
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
DB00176
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Fluvoxamine.
DB00215
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Citalopram.
DB00476
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Duloxetine.
DB00656
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Trazodone.
DB00715
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Paroxetine.
DB01104
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Sertraline.
DB01105
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Sibutramine.
DB01149
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Nefazodone.
DB01175
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Escitalopram.
DB04832
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Zimelidine.
DB04884
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Dapoxetine.
DB04896
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Milnacipran.
DB06700
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Desvenlafaxine.
DB06731
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Seproxetine.
DB08918
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Levomilnacipran.
DB08953
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Indalpine.
DB12693
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Ritanserin.
DB13233
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Alaproclate.
DB00295
The risk or severity of adverse effects can be increased when Morphine is combined with Hexamethonium.
DB00318
The risk or severity of adverse effects can be increased when Codeine is combined with Hexamethonium.
DB00327
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Hexamethonium.
DB00454
The risk or severity of adverse effects can be increased when Meperidine is combined with Hexamethonium.
DB00497
The risk or severity of adverse effects can be increased when Oxycodone is combined with Hexamethonium.
DB00611
The risk or severity of adverse effects can be increased when Butorphanol is combined with Hexamethonium.
DB00647
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Hexamethonium.
DB00652
The risk or severity of adverse effects can be increased when Pentazocine is combined with Hexamethonium.
DB00708
The risk or severity of adverse effects can be increased when Sufentanil is combined with Hexamethonium.
DB00802
The risk or severity of adverse effects can be increased when Alfentanil is combined with Hexamethonium.
DB00813
The risk or severity of adverse effects can be increased when Fentanyl is combined with Hexamethonium.
DB00844
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Hexamethonium.
DB00854
The risk or severity of adverse effects can be increased when Levorphanol is combined with Hexamethonium.
DB00899
The risk or severity of adverse effects can be increased when Remifentanil is combined with Hexamethonium.
DB01081
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Hexamethonium.
DB01192
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Hexamethonium.
DB01209
The risk or severity of adverse effects can be increased when Dezocine is combined with Hexamethonium.
DB01227
The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Hexamethonium.
DB01433
The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Hexamethonium.
DB01450
The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Hexamethonium.
DB01452
The risk or severity of adverse effects can be increased when Diamorphine is combined with Hexamethonium.
DB01466
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Hexamethonium.
DB01497
The risk or severity of adverse effects can be increased when Etorphine is combined with Hexamethonium.
DB01529
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Hexamethonium.
DB01531
The risk or severity of adverse effects can be increased when Desomorphine is combined with Hexamethonium.
DB01535
The risk or severity of adverse effects can be increased when Carfentanil is combined with Hexamethonium.
DB01551
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Hexamethonium.
DB01555
The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Hexamethonium.
DB01565
The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Hexamethonium.
DB06738
The risk or severity of adverse effects can be increased when Ketobemidone is combined with Hexamethonium.
DB08861
The risk or severity of adverse effects can be increased when DPDPE is combined with Hexamethonium.
DB09174
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lofentanil.
DB11130
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Opium.
DB11609
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Normethadone.
DB12492
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Piritramide.
DB13160
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Alphaprodine.
DB13478
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Meptazinol.
DB13605
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Phenoperidine.
DB13606
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Phenazocine.
DB13787
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tilidine.
DB15360
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Carfentanil, C-11.
DB00704
The risk or severity of adverse effects can be increased when Naltrexone is combined with Hexamethonium.
DB01459
The risk or severity of adverse effects can be increased when Bezitramide is combined with Hexamethonium.
DB13454
The risk or severity of adverse effects can be increased when Nicomorphine is combined with Hexamethonium.
DB15465
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Benzhydrocodone.
DB00235
Milrinone may increase the antihypertensive activities of Hexamethonium.
DB00820
Tadalafil may increase the antihypertensive activities of Hexamethonium.
DB00862
Vardenafil may increase the antihypertensive activities of Hexamethonium.
DB00975
Dipyridamole may increase the antihypertensive activities of Hexamethonium.
DB05266
Ibudilast may increase the antihypertensive activities of Hexamethonium.
DB06237
Avanafil may increase the antihypertensive activities of Hexamethonium.
DB06267
Udenafil may increase the antihypertensive activities of Hexamethonium.
DB09273
Doxofylline may increase the antihypertensive activities of Hexamethonium.
DB11792
Mirodenafil may increase the antihypertensive activities of Hexamethonium.
DB12010
Fostamatinib may increase the antihypertensive activities of Hexamethonium.
DB00203
Sildenafil may increase the antihypertensive activities of Hexamethonium.
DB00809
The risk or severity of adverse effects can be increased when Tropicamide is combined with Hexamethonium.
DB00915
The risk or severity of adverse effects can be increased when Amantadine is combined with Hexamethonium.
DB00979
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Hexamethonium.
DB01161
The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Hexamethonium.
DB01496
The risk or severity of adverse effects can be increased when Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione is combined with Hexamethonium.
DB08838
The risk or severity of adverse effects can be increased when Agmatine is combined with Hexamethonium.
DB11181
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Homatropine.
DB13989
The serum concentration of Epitizide can be increased when it is combined with Hexamethonium.
DB00374
Treprostinil may increase the hypotensive activities of Hexamethonium.
DB01088
Iloprost may increase the hypotensive activities of Hexamethonium.
DB01240
Epoprostenol may increase the hypotensive activities of Hexamethonium.
DB14337
Salvia miltiorrhiza root may increase the hypotensive activities of Hexamethonium.
DB00082
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Pegvisomant.
DB00358
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Mefloquine.
DB00382
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tacrine.
DB00515
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Cisplatin.
DB00527
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Cinchocaine.
DB00545
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Pyridostigmine.
DB00585
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Nizatidine.
DB00674
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Galantamine.
DB00677
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Isoflurophate.
DB00711
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Diethylcarbamazine.
DB00871
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Terbutaline.
DB00888
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Mechlorethamine.
DB00944
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Demecarium.
DB00981
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Physostigmine.
DB00989
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Rivastigmine.
DB01010
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Edrophonium.
DB01043
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Memantine.
DB01122
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ambenonium.
DB01381
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ginkgo biloba.
DB01400
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Neostigmine.
DB01408
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Bambuterol.
DB02365
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with 1,10-Phenanthroline.
DB04572
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Thiotepa.
DB04864
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Huperzine A.
DB04892
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Phenserine.
DB05386
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Regramostim.
DB06692
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Aprotinin.
DB06756
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Glycine betaine.
DB06774
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Capsaicin.
DB11390
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Coumaphos.
DB11397
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Dichlorvos.
DB11412
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Fenthion.
DB11473
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Metrifonate.
DB12482
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Acotiamide.
DB13058
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Methanesulfonyl Fluoride.
DB13495
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Paraoxon.
DB13503
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tyrothricin.
DB13668
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ipidacrine.
DB13694
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Distigmine.
DB14031
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tretamine.
DB15317
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Posiphen.
DB02845
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Methylphosphinic Acid.
DB00721
Procaine may increase the hypotensive activities of Hexamethonium.
DB00805
Minaprine may increase the hypotensive activities of Hexamethonium.
DB00182
Amphetamine may increase the hypotensive activities of Hexamethonium.
DB00601
Linezolid may increase the hypotensive activities of Hexamethonium.
DB00614
Furazolidone may increase the hypotensive activities of Hexamethonium.
DB00752
Tranylcypromine may increase the hypotensive activities of Hexamethonium.
DB00780
Phenelzine may increase the hypotensive activities of Hexamethonium.
DB01037
Selegiline may increase the hypotensive activities of Hexamethonium.
DB01168
Procarbazine may increase the hypotensive activities of Hexamethonium.
DB01171
Moclobemide may increase the hypotensive activities of Hexamethonium.
DB01247
Isocarboxazid may increase the hypotensive activities of Hexamethonium.
DB01367
Rasagiline may increase the hypotensive activities of Hexamethonium.
DB01626
Pargyline may increase the hypotensive activities of Hexamethonium.
DB04017
Clorgiline may increase the hypotensive activities of Hexamethonium.
DB04818
Iproniazid may increase the hypotensive activities of Hexamethonium.
DB04820
Nialamide may increase the hypotensive activities of Hexamethonium.
DB06654
Safinamide may increase the hypotensive activities of Hexamethonium.
DB08550
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Hexamethonium.
DB09241
Methylene blue may increase the hypotensive activities of Hexamethonium.
DB09243
Hydracarbazine may increase the hypotensive activities of Hexamethonium.
DB09244
Pirlindole may increase the hypotensive activities of Hexamethonium.
DB09245
Toloxatone may increase the hypotensive activities of Hexamethonium.
DB09246
Benmoxin may increase the hypotensive activities of Hexamethonium.
DB09248
Mebanazine may increase the hypotensive activities of Hexamethonium.
DB09249
Octamoxin may increase the hypotensive activities of Hexamethonium.
DB09250
Pheniprazine may increase the hypotensive activities of Hexamethonium.
DB09251
Phenoxypropazine may increase the hypotensive activities of Hexamethonium.
DB09252
Pivhydrazine may increase the hypotensive activities of Hexamethonium.
DB09253
Safrazine may increase the hypotensive activities of Hexamethonium.
DB09254
Caroxazone may increase the hypotensive activities of Hexamethonium.
DB13875
Harmaline may increase the hypotensive activities of Hexamethonium.
DB13876
Brofaromine may increase the hypotensive activities of Hexamethonium.
DB00392
Profenamine may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00477
Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00483
Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00508
Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB01337
Pancuronium may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB01338
Pipecuronium may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.
DB00209
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Trospium.
DB00219
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.
DB00245
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
DB00280
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
DB00321
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
DB00332
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.
DB00340
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Metixene.
DB00342
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.
DB00354
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Buclizine.
DB00376
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
DB00383
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.
DB00387
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.
DB00424
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
DB00434
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
DB00458
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Imipramine.
DB00462
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine bromide.
DB00496
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
DB00505
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.
DB00517
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Anisotropine methylbromide.
DB00540
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
DB00543
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
DB00572
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Atropine.
DB00622
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
DB00670
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.
DB00725
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.
DB00767
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Benzquinamide.
DB00777
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.
DB00782
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
DB00804
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
DB00810
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Biperiden.
DB00907
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Cocaine.
DB00934
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.
DB00940
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Methantheline.
DB00942
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Cycrimine.
DB00986
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
DB01036
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
DB01062
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
DB01142
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
DB01148
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
DB01151
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Desipramine.
DB01231
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Diphenidol.
DB01409
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Tiotropium.
DB01591
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
DB01625
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
DB04843
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.
DB06153
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.
DB06702
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
DB06787
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.
DB08801
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.
DB08897
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
DB08997
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.
DB09076
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Umeclidinium.
DB09089
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.
DB09167
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Dosulepin.
DB09262
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Imidafenacin.
DB09300
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.
DB11235
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.
DB11315
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.
DB11855
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.
DB12086
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Oxitropium.
DB12278
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Propiverine.
DB12526
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Batefenterol.
DB12554
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.
DB13252
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.
DB13254
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Prifinium.
DB13351
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.
DB13369
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Benzilone.
DB13380
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Difemerine.
DB13413
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Phenglutarimide.
DB13448
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Mazaticol.
DB13468
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Etybenzatropine.
DB13500
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Otilonium.
DB13507
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Poldine.
DB13542
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Bevonium.
DB13581
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Rociverine.
DB13619
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.
DB13636
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Etanautine.
DB13666
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Tiemonium iodide.
DB13678
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.
DB13695
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Penthienate.
DB13720
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.
DB13738
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Camylofin.
DB13759
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Fenpiverinium.
DB13769
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Emetonium iodide.
DB13844
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.
DB13850
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Timepidium.
DB09007
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.
DB01198
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Zopiclone.
DB00391
The risk or severity of adverse effects can be increased when Sulpiride is combined with Hexamethonium.
DB00941
The risk or severity of adverse effects can be increased when Hexafluronium is combined with Hexamethonium.
DB01199
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Hexamethonium.
DB01221
The risk or severity of adverse effects can be increased when Ketamine is combined with Hexamethonium.
DB01245
The risk or severity of adverse effects can be increased when Decamethonium is combined with Hexamethonium.
DB00150
The risk or severity of adverse effects can be increased when Tryptophan is combined with Hexamethonium.
DB00186
The risk or severity of adverse effects can be increased when Lorazepam is combined with Hexamethonium.
DB00189
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Hexamethonium.
DB00202
The risk or severity of adverse effects can be increased when Succinylcholine is combined with Hexamethonium.
DB00206
The risk or severity of adverse effects can be increased when Reserpine is combined with Hexamethonium.
DB00216
The risk or severity of adverse effects can be increased when Eletriptan is combined with Hexamethonium.
DB00228
The risk or severity of adverse effects can be increased when Enflurane is combined with Hexamethonium.
DB00231
The risk or severity of adverse effects can be increased when Temazepam is combined with Hexamethonium.
DB00234
The risk or severity of adverse effects can be increased when Reboxetine is combined with Hexamethonium.
DB00237
The risk or severity of adverse effects can be increased when Butabarbital is combined with Hexamethonium.
DB00241
The risk or severity of adverse effects can be increased when Butalbital is combined with Hexamethonium.
DB00247
The risk or severity of adverse effects can be increased when Methysergide is combined with Hexamethonium.
DB00248
The risk or severity of adverse effects can be increased when Cabergoline is combined with Hexamethonium.
DB00252
The risk or severity of adverse effects can be increased when Phenytoin is combined with Hexamethonium.
DB00273
The risk or severity of adverse effects can be increased when Topiramate is combined with Hexamethonium.
DB00283
The risk or severity of adverse effects can be increased when Clemastine is combined with Hexamethonium.
DB00285
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Hexamethonium.
DB00289
The risk or severity of adverse effects can be increased when Atomoxetine is combined with Hexamethonium.
DB00292
The risk or severity of adverse effects can be increased when Etomidate is combined with Hexamethonium.
DB00306
The risk or severity of adverse effects can be increased when Talbutal is combined with Hexamethonium.
DB00312
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Hexamethonium.
DB00313
The risk or severity of adverse effects can be increased when Valproic acid is combined with Hexamethonium.
DB00315
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Hexamethonium.
DB00320
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Hexamethonium.
DB00323
The risk or severity of adverse effects can be increased when Tolcapone is combined with Hexamethonium.
DB00334
The risk or severity of adverse effects can be increased when Olanzapine is combined with Hexamethonium.
DB00341
The risk or severity of adverse effects can be increased when Cetirizine is combined with Hexamethonium.
DB00344
The risk or severity of adverse effects can be increased when Protriptyline is combined with Hexamethonium.
DB00347
The risk or severity of adverse effects can be increased when Trimethadione is combined with Hexamethonium.
DB00349
The risk or severity of adverse effects can be increased when Clobazam is combined with Hexamethonium.
DB00356
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Hexamethonium.
DB00363
The risk or severity of adverse effects can be increased when Clozapine is combined with Hexamethonium.
DB00371
The risk or severity of adverse effects can be increased when Meprobamate is combined with Hexamethonium.
DB00372
The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Hexamethonium.
DB00377
The risk or severity of adverse effects can be increased when Palonosetron is combined with Hexamethonium.
DB00404
The risk or severity of adverse effects can be increased when Alprazolam is combined with Hexamethonium.
DB00405
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Hexamethonium.
DB00408
The risk or severity of adverse effects can be increased when Loxapine is combined with Hexamethonium.
DB00409
The risk or severity of adverse effects can be increased when Remoxipride is combined with Hexamethonium.
DB00416
The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Hexamethonium.
DB00418
The risk or severity of adverse effects can be increased when Secobarbital is combined with Hexamethonium.
DB00420
The risk or severity of adverse effects can be increased when Promazine is combined with Hexamethonium.
DB00423
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Hexamethonium.
DB00427
The risk or severity of adverse effects can be increased when Triprolidine is combined with Hexamethonium.
DB00433
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Hexamethonium.
DB00463
The risk or severity of adverse effects can be increased when Metharbital is combined with Hexamethonium.
DB00474
The risk or severity of adverse effects can be increased when Methohexital is combined with Hexamethonium.
DB00475
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Hexamethonium.
DB00494
The risk or severity of adverse effects can be increased when Entacapone is combined with Hexamethonium.
DB00514
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Hexamethonium.
DB00532
The risk or severity of adverse effects can be increased when Mephenytoin is combined with Hexamethonium.
DB00546
The risk or severity of adverse effects can be increased when Adinazolam is combined with Hexamethonium.
DB00555
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Hexamethonium.
DB00564
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Hexamethonium.
DB00565
The risk or severity of adverse effects can be increased when Cisatracurium is combined with Hexamethonium.
DB00574
The risk or severity of adverse effects can be increased when Fenfluramine is combined with Hexamethonium.
DB00579
The risk or severity of adverse effects can be increased when Mazindol is combined with Hexamethonium.
DB00588
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Hexamethonium.
DB00589
The risk or severity of adverse effects can be increased when Lisuride is combined with Hexamethonium.
DB00593
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Hexamethonium.
DB00599
The risk or severity of adverse effects can be increased when Thiopental is combined with Hexamethonium.
DB00604
The risk or severity of adverse effects can be increased when Cisapride is combined with Hexamethonium.
DB00617
The risk or severity of adverse effects can be increased when Paramethadione is combined with Hexamethonium.
DB00623
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Hexamethonium.
DB00625
The risk or severity of adverse effects can be increased when Efavirenz is combined with Hexamethonium.
DB00628
The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Hexamethonium.
DB00633
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Hexamethonium.
DB00645
The risk or severity of adverse effects can be increased when Dyclonine is combined with Hexamethonium.
DB00660
The risk or severity of adverse effects can be increased when Metaxalone is combined with Hexamethonium.
DB00662
The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Hexamethonium.
DB00679
The risk or severity of adverse effects can be increased when Thioridazine is combined with Hexamethonium.
DB00680
The risk or severity of adverse effects can be increased when Moricizine is combined with Hexamethonium.
DB00683
The risk or severity of adverse effects can be increased when Midazolam is combined with Hexamethonium.
DB00690
The risk or severity of adverse effects can be increased when Flurazepam is combined with Hexamethonium.
DB00696
The risk or severity of adverse effects can be increased when Ergotamine is combined with Hexamethonium.
DB00697
The risk or severity of adverse effects can be increased when Tizanidine is combined with Hexamethonium.
DB00714
The risk or severity of adverse effects can be increased when Apomorphine is combined with Hexamethonium.
DB00726
The risk or severity of adverse effects can be increased when Trimipramine is combined with Hexamethonium.
DB00728
The risk or severity of adverse effects can be increased when Rocuronium is combined with Hexamethonium.
DB00732
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Hexamethonium.
DB00734
The risk or severity of adverse effects can be increased when Risperidone is combined with Hexamethonium.
DB00737
The risk or severity of adverse effects can be increased when Meclizine is combined with Hexamethonium.
DB00740
The risk or severity of adverse effects can be increased when Riluzole is combined with Hexamethonium.
DB00747
The risk or severity of adverse effects can be increased when Scopolamine is combined with Hexamethonium.
DB00748
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Hexamethonium.
DB00753
The risk or severity of adverse effects can be increased when Isoflurane is combined with Hexamethonium.
DB00754
The risk or severity of adverse effects can be increased when Ethotoin is combined with Hexamethonium.
DB00757
The risk or severity of adverse effects can be increased when Dolasetron is combined with Hexamethonium.
DB00771
The risk or severity of adverse effects can be increased when Clidinium is combined with Hexamethonium.
DB00776
The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Hexamethonium.
DB00794
The risk or severity of adverse effects can be increased when Primidone is combined with Hexamethonium.
DB00801
The risk or severity of adverse effects can be increased when Halazepam is combined with Hexamethonium.
DB00818
The risk or severity of adverse effects can be increased when Propofol is combined with Hexamethonium.
DB00829
The risk or severity of adverse effects can be increased when Diazepam is combined with Hexamethonium.
DB00831
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Hexamethonium.
DB00832
The risk or severity of adverse effects can be increased when Phensuximide is combined with Hexamethonium.
DB00835
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Hexamethonium.
DB00837
The risk or severity of adverse effects can be increased when Progabide is combined with Hexamethonium.
DB00842
The risk or severity of adverse effects can be increased when Oxazepam is combined with Hexamethonium.
DB00849
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Hexamethonium.
DB00850
The risk or severity of adverse effects can be increased when Perphenazine is combined with Hexamethonium.
DB00865
The risk or severity of adverse effects can be increased when Benzphetamine is combined with Hexamethonium.
DB00866
The risk or severity of adverse effects can be increased when Alprenolol is combined with Hexamethonium.
DB00875
The risk or severity of adverse effects can be increased when Flupentixol is combined with Hexamethonium.
DB00889
The risk or severity of adverse effects can be increased when Granisetron is combined with Hexamethonium.
DB00897
The risk or severity of adverse effects can be increased when Triazolam is combined with Hexamethonium.
DB00904
The risk or severity of adverse effects can be increased when Ondansetron is combined with Hexamethonium.
DB00906
The risk or severity of adverse effects can be increased when Tiagabine is combined with Hexamethonium.
DB00918
The risk or severity of adverse effects can be increased when Almotriptan is combined with Hexamethonium.
DB00933
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Hexamethonium.
DB00937
The risk or severity of adverse effects can be increased when Diethylpropion is combined with Hexamethonium.
DB00949
The risk or severity of adverse effects can be increased when Felbamate is combined with Hexamethonium.
DB00952
The risk or severity of adverse effects can be increased when Naratriptan is combined with Hexamethonium.
DB00953
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Hexamethonium.
DB00960
The risk or severity of adverse effects can be increased when Pindolol is combined with Hexamethonium.
DB00962
The risk or severity of adverse effects can be increased when Zaleplon is combined with Hexamethonium.
DB00969
The risk or severity of adverse effects can be increased when Alosetron is combined with Hexamethonium.
DB00980
The risk or severity of adverse effects can be increased when Ramelteon is combined with Hexamethonium.
DB00985
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Hexamethonium.
DB00996
The risk or severity of adverse effects can be increased when Gabapentin is combined with Hexamethonium.
DB00998
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Hexamethonium.
DB01018
The risk or severity of adverse effects can be increased when Guanfacine is combined with Hexamethonium.
DB01028
The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Hexamethonium.
DB01049
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Hexamethonium.
DB01063
The risk or severity of adverse effects can be increased when Acetophenazine is combined with Hexamethonium.
DB01065
The risk or severity of adverse effects can be increased when Melatonin is combined with Hexamethonium.
DB01068
The risk or severity of adverse effects can be increased when Clonazepam is combined with Hexamethonium.
DB01069
The risk or severity of adverse effects can be increased when Promethazine is combined with Hexamethonium.
DB01075
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Hexamethonium.
DB01080
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Hexamethonium.
DB01100
The risk or severity of adverse effects can be increased when Pimozide is combined with Hexamethonium.
DB01107
The risk or severity of adverse effects can be increased when Methyprylon is combined with Hexamethonium.
DB01114
The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Hexamethonium.
DB01121
The risk or severity of adverse effects can be increased when Phenacemide is combined with Hexamethonium.
DB01135
The risk or severity of adverse effects can be increased when Doxacurium is combined with Hexamethonium.
DB01154
The risk or severity of adverse effects can be increased when Thiamylal is combined with Hexamethonium.
DB01156
The risk or severity of adverse effects can be increased when Bupropion is combined with Hexamethonium.
DB01159
The risk or severity of adverse effects can be increased when Halothane is combined with Hexamethonium.
DB01174
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Hexamethonium.
DB01176
The risk or severity of adverse effects can be increased when Cyclizine is combined with Hexamethonium.
DB01178
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Hexamethonium.
DB01186
The risk or severity of adverse effects can be increased when Pergolide is combined with Hexamethonium.
DB01189
The risk or severity of adverse effects can be increased when Desflurane is combined with Hexamethonium.
DB01200
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Hexamethonium.
DB01202
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Hexamethonium.
DB01215
The risk or severity of adverse effects can be increased when Estazolam is combined with Hexamethonium.
DB01226
The risk or severity of adverse effects can be increased when Mivacurium is combined with Hexamethonium.
DB01235
The risk or severity of adverse effects can be increased when Levodopa is combined with Hexamethonium.
DB01236
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Hexamethonium.
DB01239
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Hexamethonium.
DB01242
The risk or severity of adverse effects can be increased when Clomipramine is combined with Hexamethonium.
DB01246
The risk or severity of adverse effects can be increased when Alimemazine is combined with Hexamethonium.
DB01253
The risk or severity of adverse effects can be increased when Ergometrine is combined with Hexamethonium.
DB01267
The risk or severity of adverse effects can be increased when Paliperidone is combined with Hexamethonium.
DB01320
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Hexamethonium.
DB01323
The risk or severity of adverse effects can be increased when St. John's Wort is combined with Hexamethonium.
DB01336
The risk or severity of adverse effects can be increased when Metocurine is combined with Hexamethonium.
DB01339
The risk or severity of adverse effects can be increased when Vecuronium is combined with Hexamethonium.
DB01351
The risk or severity of adverse effects can be increased when Amobarbital is combined with Hexamethonium.
DB01352
The risk or severity of adverse effects can be increased when Aprobarbital is combined with Hexamethonium.
DB01353
The risk or severity of adverse effects can be increased when Butobarbital is combined with Hexamethonium.
DB01354
The risk or severity of adverse effects can be increased when Heptabarbital is combined with Hexamethonium.
DB01355
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Hexamethonium.
DB01356
The risk or severity of adverse effects can be increased when Lithium cation is combined with Hexamethonium.
DB01359
The risk or severity of adverse effects can be increased when Penbutolol is combined with Hexamethonium.
DB01392
The risk or severity of adverse effects can be increased when Yohimbine is combined with Hexamethonium.
DB01437
The risk or severity of adverse effects can be increased when Glutethimide is combined with Hexamethonium.
DB01440
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Hexamethonium.
DB01442
The risk or severity of adverse effects can be increased when MMDA is combined with Hexamethonium.
DB01445
The risk or severity of adverse effects can be increased when Bufotenine is combined with Hexamethonium.
DB01454
The risk or severity of adverse effects can be increased when Midomafetamine is combined with Hexamethonium.
DB01463
The risk or severity of adverse effects can be increased when Fencamfamin is combined with Hexamethonium.
DB01472
The risk or severity of adverse effects can be increased when 4-Methoxyamphetamine is combined with Hexamethonium.
DB01483
The risk or severity of adverse effects can be increased when Barbital is combined with Hexamethonium.
DB01484
The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Hexamethonium.
DB01488
The risk or severity of adverse effects can be increased when Dimethyltryptamine is combined with Hexamethonium.
DB01489
The risk or severity of adverse effects can be increased when Camazepam is combined with Hexamethonium.
DB01495
The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Hexamethonium.
DB01501
The risk or severity of adverse effects can be increased when Difenoxin is combined with Hexamethonium.
DB01509
The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Hexamethonium.
DB01511
The risk or severity of adverse effects can be increased when Delorazepam is combined with Hexamethonium.
DB01534
The risk or severity of adverse effects can be increased when Chlorhexadol is combined with Hexamethonium.
DB01544
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Hexamethonium.
DB01545
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Hexamethonium.
DB01547
The risk or severity of adverse effects can be increased when Drotebanol is combined with Hexamethonium.
DB01553
The risk or severity of adverse effects can be increased when Cloxazolam is combined with Hexamethonium.
DB01558
The risk or severity of adverse effects can be increased when Bromazepam is combined with Hexamethonium.
DB01559
The risk or severity of adverse effects can be increased when Clotiazepam is combined with Hexamethonium.
DB01560
The risk or severity of adverse effects can be increased when Cathinone is combined with Hexamethonium.
DB01563
The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Hexamethonium.
DB01567
The risk or severity of adverse effects can be increased when Fludiazepam is combined with Hexamethonium.
DB01577
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Hexamethonium.
DB01580
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Hexamethonium.
DB01587
The risk or severity of adverse effects can be increased when Ketazolam is combined with Hexamethonium.
DB01588
The risk or severity of adverse effects can be increased when Prazepam is combined with Hexamethonium.
DB01589
The risk or severity of adverse effects can be increased when Quazepam is combined with Hexamethonium.
DB01594
The risk or severity of adverse effects can be increased when Cinolazepam is combined with Hexamethonium.
DB01595
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Hexamethonium.
DB01608
The risk or severity of adverse effects can be increased when Periciazine is combined with Hexamethonium.
DB01614
The risk or severity of adverse effects can be increased when Acepromazine is combined with Hexamethonium.
DB01615
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Hexamethonium.
DB01616
The risk or severity of adverse effects can be increased when Alverine is combined with Hexamethonium.
DB01618
The risk or severity of adverse effects can be increased when Molindone is combined with Hexamethonium.
DB01621
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Hexamethonium.
DB01622
The risk or severity of adverse effects can be increased when Thioproperazine is combined with Hexamethonium.
DB01623
The risk or severity of adverse effects can be increased when Thiothixene is combined with Hexamethonium.
DB01624
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Hexamethonium.
DB01954
The risk or severity of adverse effects can be increased when Rolipram is combined with Hexamethonium.
DB02207
The risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Hexamethonium.
DB02234
The risk or severity of adverse effects can be increased when S-Ethylisothiourea is combined with Hexamethonium.
DB02852
The risk or severity of adverse effects can be increased when Domoic Acid is combined with Hexamethonium.
DB02959
The risk or severity of adverse effects can be increased when Oxitriptan is combined with Hexamethonium.
DB03575
The risk or severity of adverse effects can be increased when Phencyclidine is combined with Hexamethonium.
DB04165
The risk or severity of adverse effects can be increased when Valpromide is combined with Hexamethonium.
DB04325
The risk or severity of adverse effects can be increased when Phenethylamine is combined with Hexamethonium.
DB04599
The risk or severity of adverse effects can be increased when Aniracetam is combined with Hexamethonium.
DB04819
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Hexamethonium.
DB04821
The risk or severity of adverse effects can be increased when Nomifensine is combined with Hexamethonium.
DB04827
The risk or severity of adverse effects can be increased when Urethane is combined with Hexamethonium.
DB04829
The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Hexamethonium.
DB04833
The risk or severity of adverse effects can be increased when Methaqualone is combined with Hexamethonium.
DB04834
The risk or severity of adverse effects can be increased when Rapacuronium is combined with Hexamethonium.
DB04836
The risk or severity of adverse effects can be increased when Amineptine is combined with Hexamethonium.
DB04841
The risk or severity of adverse effects can be increased when Flunarizine is combined with Hexamethonium.
DB04842
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Hexamethonium.
DB04871
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Hexamethonium.
DB04872
The risk or severity of adverse effects can be increased when Osanetant is combined with Hexamethonium.
DB04885
The risk or severity of adverse effects can be increased when Cilansetron is combined with Hexamethonium.
DB04888
The risk or severity of adverse effects can be increased when Bifeprunox is combined with Hexamethonium.
DB04903
The risk or severity of adverse effects can be increased when Pagoclone is combined with Hexamethonium.
DB04908
The risk or severity of adverse effects can be increased when Flibanserin is combined with Hexamethonium.
DB04917
The risk or severity of adverse effects can be increased when Renzapride is combined with Hexamethonium.
DB04946
The risk or severity of adverse effects can be increased when Iloperidone is combined with Hexamethonium.
DB04953
The risk or severity of adverse effects can be increased when Ezogabine is combined with Hexamethonium.
DB05227
The risk or severity of adverse effects can be increased when APD791 is combined with Hexamethonium.
DB05232
The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Hexamethonium.
DB05246
The risk or severity of adverse effects can be increased when Methsuximide is combined with Hexamethonium.
DB05316
The risk or severity of adverse effects can be increased when Pimavanserin is combined with Hexamethonium.
DB05541
The risk or severity of adverse effects can be increased when Brivaracetam is combined with Hexamethonium.
DB05542
The risk or severity of adverse effects can be increased when Naronapride is combined with Hexamethonium.
DB05562
The risk or severity of adverse effects can be increased when Naluzotan is combined with Hexamethonium.
DB05607
The risk or severity of adverse effects can be increased when PRX-08066 is combined with Hexamethonium.
DB05687
The risk or severity of adverse effects can be increased when BL-1020 is combined with Hexamethonium.
DB05710
The risk or severity of adverse effects can be increased when Gantacurium is combined with Hexamethonium.
DB06016
The risk or severity of adverse effects can be increased when Cariprazine is combined with Hexamethonium.
DB06077
The risk or severity of adverse effects can be increased when Lumateperone is combined with Hexamethonium.
DB06109
The risk or severity of adverse effects can be increased when YKP-1358 is combined with Hexamethonium.
DB06144
The risk or severity of adverse effects can be increased when Sertindole is combined with Hexamethonium.
DB06148
The risk or severity of adverse effects can be increased when Mianserin is combined with Hexamethonium.
DB06216
The risk or severity of adverse effects can be increased when Asenapine is combined with Hexamethonium.
DB06218
The risk or severity of adverse effects can be increased when Lacosamide is combined with Hexamethonium.
DB06264
The risk or severity of adverse effects can be increased when Tolperisone is combined with Hexamethonium.
DB06282
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Hexamethonium.
DB06283
The risk or severity of adverse effects can be increased when Ziconotide is combined with Hexamethonium.
DB06288
The risk or severity of adverse effects can be increased when Amisulpride is combined with Hexamethonium.
DB06446
The risk or severity of adverse effects can be increased when Dotarizine is combined with Hexamethonium.
DB06458
The risk or severity of adverse effects can be increased when Remacemide is combined with Hexamethonium.
DB06470
The risk or severity of adverse effects can be increased when Clomethiazole is combined with Hexamethonium.
DB06512
The risk or severity of adverse effects can be increased when Deramciclane is combined with Hexamethonium.
DB06527
The risk or severity of adverse effects can be increased when Tramiprosate is combined with Hexamethonium.
DB06529
The risk or severity of adverse effects can be increased when Ocinaplon is combined with Hexamethonium.
DB06554
The risk or severity of adverse effects can be increased when Gaboxadol is combined with Hexamethonium.
DB06579
The risk or severity of adverse effects can be increased when Adipiplon is combined with Hexamethonium.
DB06582
The risk or severity of adverse effects can be increased when Dextofisopam is combined with Hexamethonium.
DB06594
The risk or severity of adverse effects can be increased when Agomelatine is combined with Hexamethonium.
DB06660
The risk or severity of adverse effects can be increased when Saredutant is combined with Hexamethonium.
DB06678
The risk or severity of adverse effects can be increased when Esmirtazapine is combined with Hexamethonium.
DB06684
The risk or severity of adverse effects can be increased when Vilazodone is combined with Hexamethonium.
DB06690
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Hexamethonium.
DB06691
The risk or severity of adverse effects can be increased when Mepyramine is combined with Hexamethonium.
DB06716
The risk or severity of adverse effects can be increased when Fospropofol is combined with Hexamethonium.
DB06753
The risk or severity of adverse effects can be increased when Triclofos is combined with Hexamethonium.
DB06770
The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Hexamethonium.
DB06797
The risk or severity of adverse effects can be increased when Mebutamate is combined with Hexamethonium.
DB08059
The risk or severity of adverse effects can be increased when Wortmannin is combined with Hexamethonium.
DB08329
The risk or severity of adverse effects can be increased when Sulthiame is combined with Hexamethonium.
DB08810
The risk or severity of adverse effects can be increased when Cinitapride is combined with Hexamethonium.
DB08811
The risk or severity of adverse effects can be increased when Tofisopam is combined with Hexamethonium.
DB08815
The risk or severity of adverse effects can be increased when Lurasidone is combined with Hexamethonium.
DB08839
The risk or severity of adverse effects can be increased when Serotonin is combined with Hexamethonium.
DB08872
The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Hexamethonium.
DB08892
The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Hexamethonium.
DB08910
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Hexamethonium.
DB08922
The risk or severity of adverse effects can be increased when Perospirone is combined with Hexamethonium.
DB08927
The risk or severity of adverse effects can be increased when Amperozide is combined with Hexamethonium.
DB08954
The risk or severity of adverse effects can be increased when Ifenprodil is combined with Hexamethonium.
DB08986
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Etifoxine.
DB08992
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Eperisone.
DB08996
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Dimetacrine.
DB09000
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Cyamemazine.
DB09001
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Barbexaclone.
DB09011
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Beclamide.
DB09014
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Captodiame.
DB09016
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Butriptyline.
DB09017
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Brotizolam.
DB09021
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Benzoctamine.
DB09023
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Benactyzine.
DB09068
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Vortioxetine.
DB09071
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tasimelteon.
DB09118
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Stiripentol.
DB09119
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Eslicarbazepine acetate.
DB09128
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Brexpiprazole.
DB09166
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Etizolam.
DB09184
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Edivoxetine.
DB09185
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Viloxazine.
DB09186
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Nisoxetine.
DB09187
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lortalamine.
DB09190
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Talopram.
DB09194
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Etoperidone.
DB09223
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Blonanserin.
DB09224
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Melperone.
DB09225
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Zotepine.
DB09226
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Brilaroxazine.
DB09247
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Iproclozide.
DB09286
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pipamperone.
DB09289
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tianeptine.
DB09290
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Ramosetron.
DB09307
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Oxaprotiline.
DB11156
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pyrantel.
DB11371
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Alfaxalone.
DB11376
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Azaperone.
DB11400
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Doramectin.
DB11428
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Medetomidine.
DB11477
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Xylazine.
DB11540
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Propiopromazine.
DB11543
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Romifidine.
DB11549
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tiletamine.
DB11552
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tricaine.
DB11555
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Zolazepam.
DB11556
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Detomidine.
DB11582
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Thiocolchicoside.
DB11664
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Psilocybin.
DB11675
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Mosapride.
DB11686
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Iferanserin.
DB11699
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tropisetron.
DB11755
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tetrahydrocannabivarin.
DB11859
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Brexanolone.
DB11868
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Etiracetam.
DB11889
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lanicemine.
DB11957
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Idalopirdine.
DB12071
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Vabicaserin.
DB12093
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tetrahydropalmatine.
DB12105
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Imagabalin.
DB12110
The risk or severity of adverse effects can be increased when Hexamethonium is combined with m-Chlorophenylpiperazine.
DB12111
The risk or severity of adverse effects can be increased when Hexamethonium is combined with MK-212.
DB12131
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Vinpocetine.
DB12163
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Sarpogrelate.
DB12177
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Eplivanserin.
DB12184
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Gepirone.
DB12229
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Cerlapirdine.
DB12273
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Ecopipam.
DB12308
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Eltanolone.
DB12327
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Salvinorin A.
DB12338
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Carisbamate.
DB12361
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Piclozotan.
DB12395
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Esreboxetine.
DB12401
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Bromperidol.
DB12427
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Orvepitant.
DB12465
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Ketanserin.
DB12518
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Raclopride.
DB12537
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Benzodiazepine.
DB12576
The risk or severity of adverse effects can be increased when Hexamethonium is combined with AZD-3043.
DB12590
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Indiplon.
DB12661
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Urapidil.
DB12710
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Perazine.
DB12725
The risk or severity of adverse effects can be increased when Hexamethonium is combined with TD-8954.
DB12833
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tandospirone.
DB12867
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Benperidol.
DB12883
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Eltoprazine.
DB12930
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Opipramol.
DB12951
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pivagabine.
DB12958
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Prothipendyl.
DB12989
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Neosaxitoxin.
DB13014
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Hypericin.
DB13025
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tiapride.
DB13082
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Nefiracetam.
DB13099
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Valnoctamide.
DB13114
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Amitriptylinoxide.
DB13213
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Butaperazine.
DB13219
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Medifoxamine.
DB13221
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Apronalide.
DB13225
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Dibenzepin.
DB13234
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Propanidid.
DB13246
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Quinupramine.
DB13253
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Proxibarbal.
DB13256
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Clothiapine.
DB13273
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Sultopride.
DB13295
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Atracurium.
DB13303
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Febarbamate.
DB13323
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Trichloroethylene.
DB13324
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Tetrazepam.
DB13331
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pyrithyldione.
DB13335
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pinazepam.
DB13352
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Deanol.
DB13354
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Phenprobamate.
DB13357
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Styramate.
DB13362
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pheneturide.
DB13370
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Bromisoval.
DB13377
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Vinbarbital.
DB13382
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Chlorproethazine.
DB13384
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Melitracen.
DB13396
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Neocitrullamon.
DB13402
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Acetylglycinamide chloral hydrate.
DB13403
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Oxypertine.
DB13411
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lofepramine.
DB13414
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Fenyramidol.
DB13420
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Thiazinam.
DB13437
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Medazepam.
DB13455
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Phenibut.
DB13457
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Oxaflozane.
DB13496
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Iprindole.
DB13505
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Emepronium.
DB13520
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Metergoline.
DB13522
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Mebicar.
DB13523
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Veralipride.
DB13534
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Gedocarnil.
DB13541
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Iprazochrome.
DB13550
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Bifemelane.
DB13552
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Trifluperidol.
DB13554
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Moperone.
DB13557
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Thiopropazate.
DB13572
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Emylcamate.
DB13577
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Allobarbital.
DB13584
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Gallamine.
DB13588
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Naftidrofuryl.
DB13598
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Diethyl ether.
DB13601
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Oxiracetam.
DB13623
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Fabomotizole.
DB13642
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pridinol.
DB13643
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Loprazolam.
DB13648
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Alcuronium.
DB13662
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Hexapropymate.
DB13665
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Fluanisone.
DB13676
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Mosapramine.
DB13687
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Niaprazine.
DB13690
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Vinyl ether.
DB13733
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Methylpentynol.
DB13737
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Cyclobarbital.
DB13745
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Fazadinium bromide.
DB13754
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Mephenoxalone.
DB13770
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Vinylbital.
DB13782
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Imipramine oxide.
DB13784
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Dixyrazine.
DB13791
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Penfluridol.
DB13799
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Ethadione.
DB13805
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Reposal.
DB13817
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Carbromal.
DB13837
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Doxefazepam.
DB13841
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Clopenthixol.
DB13872
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lormetazepam.
DB13940
The risk or severity of adverse effects can be increased when Hexamethonium is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
DB13948
The risk or severity of adverse effects can be increased when Hexamethonium is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.
DB13984
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Cyclopropane.
DB13993
The risk or severity of adverse effects can be increased when Hexamethonium is combined with MRK-409.
DB14010
The risk or severity of adverse effects can be increased when Hexamethonium is combined with 5-methoxy-N,N-dimethyltryptamine.
DB14028
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Nordazepam.
DB14050
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Cannabidivarin.
DB14509
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lithium carbonate.
DB14575
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Eslicarbazepine.
DB14651
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Perphenazine enanthate.
DB14672
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Oxazepam acetate.
DB14715
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Cinazepam.
DB14718
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Pyrazolam.
DB14719
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Bentazepam.
DB14754
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Solriamfetol.
DB15203
The risk or severity of adverse effects can be increased when Hexamethonium is combined with JNJ-26489112.
DB00967
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Desloratadine.
DB11951
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lemborexant.
DB00751
The risk or severity of adverse effects can be increased when Epinastine is combined with Hexamethonium.
DB00230
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Pregabalin.
DB00159
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Icosapent.
DB00244
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Mesalazine.
DB00328
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Indomethacin.
DB00461
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Nabumetone.
DB00465
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ketorolac.
DB00469
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tenoxicam.
DB00500
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tolmetin.
DB00533
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Rofecoxib.
DB00554
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Piroxicam.
DB00573
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Fenoprofen.
DB00580
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Valdecoxib.
DB00586
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Diclofenac.
DB00605
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Sulindac.
DB00712
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Flurbiprofen.
DB00749
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Etodolac.
DB00784
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Mefenamic acid.
DB00788
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Naproxen.
DB00812
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Phenylbutazone.
DB00814
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Meloxicam.
DB00821
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Carprofen.
DB00861
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Diflunisal.
DB00936
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Salicylic acid.
DB00939
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Meclofenamic acid.
DB00991
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Oxaprozin.
DB01009
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ketoprofen.
DB01014
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Balsalazide.
DB01050
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ibuprofen.
DB01250
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Olsalazine.
DB01283
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Lumiracoxib.
DB01397
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Magnesium salicylate.
DB01399
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Salsalate.
DB01401
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Choline magnesium trisalicylate.
DB01419
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Antrafenine.
DB01424
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Aminophenazone.
DB01435
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Antipyrine.
DB01600
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tiaprofenic acid.
DB01628
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Etoricoxib.
DB02224
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Taxifolin.
DB03585
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Oxyphenbutazone.
DB04725
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Licofelone.
DB04743
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Nimesulide.
DB04812
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Benoxaprofen.
DB04817
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Metamizole.
DB04828
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Zomepirac.
DB05095
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Cimicoxib.
DB06725
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Lornoxicam.
DB06736
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Aceclofenac.
DB06737
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Zaltoprofen.
DB07402
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Azapropazone.
DB08439
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Parecoxib.
DB08797
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Salicylamide.
DB08940
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Kebuzone.
DB08942
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Isoxicam.
DB08951
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Indoprofen.
DB08955
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ibuproxam.
DB08976
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Floctafenine.
DB08981
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Fenbufen.
DB08984
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Etofenamate.
DB08991
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Epirizole.
DB09084
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Benzydamine.
DB09213
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Dexibuprofen.
DB09214
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Dexketoprofen.
DB09215
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Droxicam.
DB09216
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tolfenamic acid.
DB09217
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Firocoxib.
DB09218
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Clonixin.
DB09285
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Morniflumate.
DB09288
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Propacetamol.
DB09295
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Talniflumate.
DB11455
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Robenacoxib.
DB11466
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tepoxalin.
DB11518
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Flunixin.
DB12399
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Polmacoxib.
DB12445
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Nitroaspirin.
DB12545
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Indobufen.
DB12610
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ebselen.
DB13001
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tinoridine.
DB13167
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Alclofenac.
DB13217
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Fentiazac.
DB13232
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Suxibuzone.
DB13286
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Bumadizone.
DB13314
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Alminoprofen.
DB13371
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Difenpiramide.
DB13407
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Nifenazone.
DB13432
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Lonazolac.
DB13481
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Tenidap.
DB13524
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Propyphenazone.
DB13527
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Proglumetacin.
DB13538
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Guacetisal.
DB13544
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ethenzamide.
DB13612
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Carbaspirin calcium.
DB13629
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Mofebutazone.
DB13649
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Proquazone.
DB13657
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Benorilate.
DB13722
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Pirprofen.
DB13783
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Acemetacin.
DB13860
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Imidazole salicylate.
DB14059
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with SC-236.
DB14060
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with NS-398.
DB14938
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Flurbiprofen axetil.
DB09212
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Loxoprofen.
DB09227
Hexamethonium may increase the antihypertensive activities of Barnidipine.
DB09532
The therapeutic efficacy of Secretin human can be decreased when used in combination with Hexamethonium.
DB04948
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Lofexidine.
DB00091
The risk or severity of adverse effects can be increased when Cyclosporine is combined with Hexamethonium.
DB00254
The risk or severity of adverse effects can be increased when Doxycycline is combined with Hexamethonium.
DB00256
The risk or severity of adverse effects can be increased when Lymecycline is combined with Hexamethonium.
DB00314
The risk or severity of adverse effects can be increased when Capreomycin is combined with Hexamethonium.
DB00319
The risk or severity of adverse effects can be increased when Piperacillin is combined with Hexamethonium.
DB00452
The risk or severity of adverse effects can be increased when Framycetin is combined with Hexamethonium.
DB00453
The risk or severity of adverse effects can be increased when Clomocycline is combined with Hexamethonium.
DB00468
The risk or severity of adverse effects can be increased when Quinine is combined with Hexamethonium.
DB00512
The risk or severity of adverse effects can be increased when Vancomycin is combined with Hexamethonium.
DB00560
The risk or severity of adverse effects can be increased when Tigecycline is combined with Hexamethonium.
DB00595
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Hexamethonium.
DB00608
The risk or severity of adverse effects can be increased when Chloroquine is combined with Hexamethonium.
DB00618
The risk or severity of adverse effects can be increased when Demeclocycline is combined with Hexamethonium.
DB00657
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Hexamethonium.
DB00684
The risk or severity of adverse effects can be increased when Tobramycin is combined with Hexamethonium.
DB00759
The risk or severity of adverse effects can be increased when Tetracycline is combined with Hexamethonium.
DB00798
The risk or severity of adverse effects can be increased when Gentamicin is combined with Hexamethonium.
DB00903
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Hexamethonium.
DB00908
The risk or severity of adverse effects can be increased when Quinidine is combined with Hexamethonium.
DB00931
The risk or severity of adverse effects can be increased when Metacycline is combined with Hexamethonium.
DB00955
The risk or severity of adverse effects can be increased when Netilmicin is combined with Hexamethonium.
DB00994
The risk or severity of adverse effects can be increased when Neomycin is combined with Hexamethonium.
DB01035
The risk or severity of adverse effects can be increased when Procainamide is combined with Hexamethonium.
DB01082
The risk or severity of adverse effects can be increased when Streptomycin is combined with Hexamethonium.
DB01111
The risk or severity of adverse effects can be increased when Colistimethate is combined with Hexamethonium.
DB01172
The risk or severity of adverse effects can be increased when Kanamycin is combined with Hexamethonium.
DB01190
The risk or severity of adverse effects can be increased when Clindamycin is combined with Hexamethonium.
DB01219
The risk or severity of adverse effects can be increased when Dantrolene is combined with Hexamethonium.
DB01301
The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Hexamethonium.
DB01377
The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Hexamethonium.
DB01378
The risk or severity of adverse effects can be increased when Magnesium cation is combined with Hexamethonium.
DB01421
The risk or severity of adverse effects can be increased when Paromomycin is combined with Hexamethonium.
DB01627
The risk or severity of adverse effects can be increased when Lincomycin is combined with Hexamethonium.
DB03615
The risk or severity of adverse effects can be increased when Ribostamycin is combined with Hexamethonium.
DB04263
The risk or severity of adverse effects can be increased when Geneticin is combined with Hexamethonium.
DB04626
The risk or severity of adverse effects can be increased when Apramycin is combined with Hexamethonium.
DB04729
The risk or severity of adverse effects can be increased when Gentamicin C1a is combined with Hexamethonium.
DB04808
The risk or severity of adverse effects can be increased when Neamine is combined with Hexamethonium.
DB06696
The risk or severity of adverse effects can be increased when Arbekacin is combined with Hexamethonium.
DB06827
The risk or severity of adverse effects can be increased when Viomycin is combined with Hexamethonium.
DB08437
The risk or severity of adverse effects can be increased when Puromycin is combined with Hexamethonium.
DB09104
The risk or severity of adverse effects can be increased when Magnesium hydroxide is combined with Hexamethonium.
DB09281
The risk or severity of adverse effects can be increased when Magnesium trisilicate is combined with Hexamethonium.
DB09407
The risk or severity of adverse effects can be increased when Magnesium chloride is combined with Hexamethonium.
DB09409
The risk or severity of adverse effects can be increased when Magnesium acetate tetrahydrate is combined with Hexamethonium.
DB09481
The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Hexamethonium.
DB11110
The risk or severity of adverse effects can be increased when Magnesium citrate is combined with Hexamethonium.
DB11189
The risk or severity of adverse effects can be increased when Magnesium glycinate is combined with Hexamethonium.
DB11230
The risk or severity of adverse effects can be increased when Magnesium Aluminum Silicate is combined with Hexamethonium.
DB11512
The risk or severity of adverse effects can be increased when Dihydrostreptomycin is combined with Hexamethonium.
DB11520
The risk or severity of adverse effects can be increased when Hygromycin B is combined with Hexamethonium.
DB12604
The risk or severity of adverse effects can be increased when Sisomicin is combined with Hexamethonium.
DB12615
The risk or severity of adverse effects can be increased when Plazomicin is combined with Hexamethonium.
DB13249
The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Hexamethonium.
DB13264
The risk or severity of adverse effects can be increased when Penimepicycline is combined with Hexamethonium.
DB13359
The risk or severity of adverse effects can be increased when Magnesium aspartate is combined with Hexamethonium.
DB13540
The risk or severity of adverse effects can be increased when Isepamicin is combined with Hexamethonium.
DB13749
The risk or severity of adverse effects can be increased when Magnesium gluconate is combined with Hexamethonium.
DB13786
The risk or severity of adverse effects can be increased when Magnesium orotate is combined with Hexamethonium.
DB13862
The risk or severity of adverse effects can be increased when Magnesium phosphate is combined with Hexamethonium.
DB13996
The risk or severity of adverse effects can be increased when Magnesium acetate is combined with Hexamethonium.
DB14077
The risk or severity of adverse effects can be increased when Magnesium stearate is combined with Hexamethonium.
DB00803
The risk or severity of adverse effects can be increased when Colistin is combined with Hexamethonium.
DB00581
The therapeutic efficacy of Lactulose can be decreased when used in combination with Hexamethonium.
DB01046
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Hexamethonium.
DB01079
The therapeutic efficacy of Tegaserod can be decreased when used in combination with Hexamethonium.
DB01593
The therapeutic efficacy of Zinc can be decreased when used in combination with Hexamethonium.
DB01638
The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hexamethonium.
DB04816
The therapeutic efficacy of Dantron can be decreased when used in combination with Hexamethonium.
DB04823
The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Hexamethonium.
DB04824
The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Hexamethonium.
DB07715
The therapeutic efficacy of Emodin can be decreased when used in combination with Hexamethonium.
DB08890
The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hexamethonium.
DB09020
The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hexamethonium.
DB09219
The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Hexamethonium.
DB09268
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Hexamethonium.
DB09287
The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Hexamethonium.
DB09311
The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Hexamethonium.
DB09413
The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Hexamethonium.
DB09414
The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Hexamethonium.
DB09449
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Hexamethonium.
DB09462
The therapeutic efficacy of Glycerin can be decreased when used in combination with Hexamethonium.
DB09472
The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Hexamethonium.
DB09484
The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Hexamethonium.
DB11057
The therapeutic efficacy of Mineral oil can be decreased when used in combination with Hexamethonium.
DB11059
The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Hexamethonium.
DB11089
The therapeutic efficacy of Docusate can be decreased when used in combination with Hexamethonium.
DB11097
The therapeutic efficacy of Plantago seed can be decreased when used in combination with Hexamethonium.
DB11113
The therapeutic efficacy of Castor oil can be decreased when used in combination with Hexamethonium.
DB11228
The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Hexamethonium.
DB11365
The therapeutic efficacy of Sennosides can be decreased when used in combination with Hexamethonium.
DB12942
The therapeutic efficacy of Lactitol can be decreased when used in combination with Hexamethonium.
DB13170
The therapeutic efficacy of Plecanatide can be decreased when used in combination with Hexamethonium.
DB13486
The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Hexamethonium.
DB13526
The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Hexamethonium.
DB13707
The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Hexamethonium.
DB14232
The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Hexamethonium.
DB14482
The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Hexamethonium.
DB14499
The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Hexamethonium.
DB14502
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Hexamethonium.
DB14503
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Hexamethonium.
DB14504
The therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Hexamethonium.
DB14513
The therapeutic efficacy of Magnesium can be decreased when used in combination with Hexamethonium.
DB14585
The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Hexamethonium.
DB14627
The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hexamethonium.
DB14684
The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Hexamethonium.
DB14963
The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Hexamethonium.
DB06480
The therapeutic efficacy of Prucalopride can be decreased when used in combination with Hexamethonium.
DB15477
The therapeutic efficacy of Alloin can be decreased when used in combination with Hexamethonium.
DB15478
The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Hexamethonium.
DB11622
The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Hexamethonium.
DB14516
The therapeutic efficacy of Sodium cation can be decreased when used in combination with Hexamethonium.
DB14546
The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Hexamethonium.
DB05077
The risk or severity of adverse effects can be increased when SLV319 is combined with Hexamethonium.
DB06155
The risk or severity of adverse effects can be increased when Rimonabant is combined with Hexamethonium.
DB06624
The risk or severity of adverse effects can be increased when Taranabant is combined with Hexamethonium.
DB09061
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexamethonium.
DB11903
The risk or severity of adverse effects can be increased when GW842166 is combined with Hexamethonium.
DB12193
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Hexamethonium.
DB12649
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Hexamethonium.
DB13070
The risk or severity of adverse effects can be increased when Surinabant is combined with Hexamethonium.
DB13950
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Hexamethonium.
DB14011
The risk or severity of adverse effects can be increased when Nabiximols is combined with Hexamethonium.
DB14043
The risk or severity of adverse effects can be increased when Palmidrol is combined with Hexamethonium.
DB14737
The risk or severity of adverse effects can be increased when Cannabinol is combined with Hexamethonium.
DB00181
The risk or severity of adverse effects can be increased when Baclofen is combined with Hexamethonium.
DB00455
Hexamethonium may increase the anticholinergic activities of Loratadine.
DB09272
The risk or severity of constipation can be increased when Hexamethonium is combined with Eluxadoline.
DB00190
The risk or severity of hypotension can be increased when Carbidopa is combined with Hexamethonium.
DB11823
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Esketamine.
DB00395
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Hexamethonium.
DB00457
The risk or severity of hypotension can be increased when Prazosin is combined with Hexamethonium.
DB00041
Aldesleukin may increase the hypotensive activities of Hexamethonium.
DB00086
Streptokinase may increase the hypotensive activities of Hexamethonium.
DB00296
Ropivacaine may increase the hypotensive activities of Hexamethonium.
DB00297
Bupivacaine may increase the hypotensive activities of Hexamethonium.
DB00384
Triamterene may increase the hypotensive activities of Hexamethonium.
DB00421
Spironolactone may increase the hypotensive activities of Hexamethonium.
DB00435
Nitric Oxide may increase the hypotensive activities of Hexamethonium.
DB00489
Sotalol may increase the hypotensive activities of Hexamethonium.
DB00594
Amiloride may increase the hypotensive activities of Hexamethonium.
DB00631
Clofarabine may increase the hypotensive activities of Hexamethonium.
DB00661
Verapamil may increase the hypotensive activities of Hexamethonium.
DB00681
Amphotericin B may increase the hypotensive activities of Hexamethonium.
DB00742
Mannitol may increase the hypotensive activities of Hexamethonium.
DB00755
Tretinoin may increase the hypotensive activities of Hexamethonium.
DB00872
Conivaptan may increase the hypotensive activities of Hexamethonium.
DB00883
Isosorbide dinitrate may increase the hypotensive activities of Hexamethonium.
DB00922
Levosimendan may increase the hypotensive activities of Hexamethonium.
DB01002
Levobupivacaine may increase the hypotensive activities of Hexamethonium.
DB01020
Isosorbide mononitrate may increase the hypotensive activities of Hexamethonium.
DB01113
Papaverine may increase the hypotensive activities of Hexamethonium.
DB01115
Nifedipine may increase the hypotensive activities of Hexamethonium.
DB01118
Amiodarone may increase the hypotensive activities of Hexamethonium.
DB01169
Arsenic trioxide may increase the hypotensive activities of Hexamethonium.
DB01229
Paclitaxel may increase the hypotensive activities of Hexamethonium.
DB01282
Carbetocin may increase the hypotensive activities of Hexamethonium.
DB01612
Amyl Nitrite may increase the hypotensive activities of Hexamethonium.
DB04899
Nesiritide may increase the hypotensive activities of Hexamethonium.
DB04920
Clevidipine may increase the hypotensive activities of Hexamethonium.
DB06292
Dapagliflozin may increase the hypotensive activities of Hexamethonium.
DB08822
Azilsartan medoxomil may increase the hypotensive activities of Hexamethonium.
DB08907
Canagliflozin may increase the hypotensive activities of Hexamethonium.
DB09038
Empagliflozin may increase the hypotensive activities of Hexamethonium.
DB09077
Dinutuximab may increase the hypotensive activities of Hexamethonium.
DB09112
Nitrous acid may increase the hypotensive activities of Hexamethonium.
DB09204
Arotinolol may increase the hypotensive activities of Hexamethonium.
DB09232
Cilnidipine may increase the hypotensive activities of Hexamethonium.
DB09279
Fimasartan may increase the hypotensive activities of Hexamethonium.
DB09292
Sacubitril may increase the hypotensive activities of Hexamethonium.
DB01238
The risk or severity of hypotension can be increased when Aripiprazole is combined with Hexamethonium.
DB14185
The risk or severity of hypotension can be increased when Aripiprazole lauroxil is combined with Hexamethonium.
DB00402
The risk or severity of CNS depression can be increased when Hexamethonium is combined with Eszopiclone.
DB00575
The risk or severity of sedation can be increased when Clonidine is combined with Hexamethonium.
DB00843
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Donepezil.
DB00924
The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Hexamethonium.
DB01233
The risk or severity of sedation can be increased when Metoclopramide is combined with Hexamethonium.
DB01224
Quetiapine may increase the hypotensive activities of Hexamethonium.
DB11732
The risk or severity of adverse effects can be increased when Hexamethonium is combined with Lasmiditan.
DB00193
The risk or severity of CNS depression can be increased when Hexamethonium is combined with Tramadol.
DB00246
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Hexamethonium.
DB00232
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Methyclothiazide.
DB00436
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Bendroflumethiazide.
DB00562
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Benzthiazide.
DB00606
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Cyclothiazide.
DB00774
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Hydroflumethiazide.
DB00880
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Chlorothiazide.
DB00999
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Hydrochlorothiazide.
DB01021
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Trichlormethiazide.
DB01324
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Polythiazide.
DB13430
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Mebutizide.
DB13532
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Cyclopenthiazide.
DB00502
The risk or severity of CNS depression can be increased when Haloperidol is combined with Hexamethonium.
DB00472
Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.
DB00808
The therapeutic efficacy of Hexamethonium can be increased when used in combination with Indapamide.
DB12404
The risk or severity of sedation can be increased when Hexamethonium is combined with Remimazolam.
DB14881
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Hexamethonium is combined with Oliceridine.

序列

实验性质

Melting Point
290-291
U.S. Patent 2,641,610.

外部标识符

resource：ChEBI
identifier：5700
resource：PubChem Compound
identifier：3604
resource：PubChem Substance
identifier：310264925
resource：KEGG Compound
identifier：C07510
resource：ChemSpider
identifier：3478
resource：BindingDB
identifier：50038416
resource：Wikipedia
identifier：Hexamethonium
resource：ChEMBL
identifier：CHEMBL100622
resource：ZINC
identifier：ZINC000001530808

外部链接

路径

目标

id:BE0000738
name:Neuronal acetylcholine receptor subunit alpha-2
organism:Humans
action:antagonist
Zhou X, Ren J, Brown E, Schneider D, Caraballo-Lopez Y, Galligan JJ: Pharmacological properties of nicotinic acetylcholine receptors expressed by guinea pig small intestinal myenteric neurons. J Pharmacol Exp Ther. 2002 Sep;302(3):889-97. doi: 10.1124/jpet.102.033548.
Loiacono R, Stephenson J, Stevenson J, Mitchelson F: Multiple binding sites for nicotine receptor antagonists in inhibiting [3H](-)-nicotine binding in rat cortex. Neuropharmacology. 1993 Sep;32(9):847-53.
known-action:yes
name:Neuronal acetylcholine receptor subunit alpha-2
general-function:Drug binding
specific-function:After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
gene-name:CHRNA2
locus:8p21
cellular-location:Cell junction
transmembrane-regions:265-289 297-315 331-352 503-521
signal-regions:1-26
theoretical-pi:6.02
molecular-weight:59764.82
chromosome-location:8
organism:Humans
external-identifiers:HUGO Gene Nomenclature Committee (HGNC)HGNC:1956GenAtlasCHRNA2GenBank Gene DatabaseU62431GenBank Protein Database1458110IUPHAR463Guide to Pharmacology463UniProtKBQ15822UniProt AccessionACHA2_HUMAN
synonyms:Neuronal acetylcholine receptor subunit alpha-2 precursor
amino-acid-sequence:>lcl|BSEQ0037067|Neuronal acetylcholine receptor subunit alpha-2 MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALPQGGSHTETED RLFKHLFRGYNRWARPVPNTSDVVIVRFGLSIAQLIDVDEKNQMMTTNVWLKQEWSDYKL RWNPTDFGNITSLRVPSEMIWIPDIVLYNNADGEFAVTHMTKAHLFSTGTVHWVPPAIYK SSCSIDVTFFPFDQQNCKMKFGSWTYDKAKIDLEQMEQTVDLKDYWESGEWAIVNATGTY NSKKYDCCAEIYPDVTYAFVIRRLPLFYTINLIIPCLLISCLTVLVFYLPSDCGEKITLC ISVLLSLTVFLLLITEIIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHHRSPSTH TMPHWVRGALLGCVPRWLLMNRPPPPVELCHPLRLKLSPSYHWLESNVDAEEREVVVEEE DRWACAGHVAPSVGTLCSHGHLHSGASGPKAEALLQEGELLLSPHMQKALEGVHYIADHL RSEDADSSVKEDWKYVAMVIDRIFLWLFIIVCFLGTIGLFLPPFLAGMI
gene-sequence:>lcl|BSEQ0010520|Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2) ATGGGCCCCTCCTGTCCTGTGTTCCTGTCCTTCACAAAGCTCAGCCTGTGGTGGCTCCTT CTGACCCCAGCAGGTGGAGAGGAAGCTAAGCGCCCACCTCCCAGGGCTCCTGGAGACCCA CTCTCCTCTCCCAGTCCCACGGCATTGCCGCAGGGAGGCTCGCATACCGAGACTGAGGAC CGGCTCTTCAAACACCTCTTCCGGGGCTACAACCGCTGGGCGCGCCCGGTGCCCAACACT TCAGACGTGGTGATTGTGCGCTTTGGACTGTCCATCGCTCAGCTCATCGATGTGGATGAG AAGAACCAAATGATGACCACCAACGTCTGGCTAAAACAGGAGTGGAGCGACTACAAACTG CGCTGGAACCCCACTGATTTTGGCAACATCACATCTCTCAGGGTCCCTTCTGAGATGATC TGGATCCCCGACATTGTTCTCTACAACAATGCAGATGGGGAGTTTGCAGTGACCCACATG ACCAAGGCCCACCTCTTCTCCACGGGCACTGTGCACTGGGTGCCCCCGGCCATCTACAAG AGCTCCTGCAGCATCGACGTCACCTTCTTCCCCTTCGACCAGCAGAACTGCAAGATGAAG TTTGGCTCCTGGACTTATGACAAGGCCAAGATCGACCTGGAGCAGATGGAGCAGACTGTG GACCTGAAGGACTACTGGGAGAGCGGCGAGTGGGCCATCGTCAATGCCACGGGCACCTAC AACAGCAAGAAGTACGACTGCTGCGCCGAGATCTACCCCGACGTCACCTACGCCTTCGTC ATCCGGCGGCTGCCGCTCTTCTACACCATCAACCTCATCATCCCCTGCCTGCTCATCTCC TGCCTCACTGTGCTGGTCTTCTACCTGCCCTCCGACTGCGGCGAGAAGATCACGCTGTGC ATTTCGGTGCTGCTGTCACTCACCGTCTTCCTGCTGCTCATCACTGAGATCATCCCGTCC ACCTCGCTGGTCATCCCGCTCATCGGCGAGTACCTGCTGTTCACCATGATCTTCGTCACC CTGTCCATCGTCATCACCGTCTTCGTGCTCAATGTGCACCACCGCTCCCCCAGCACCCAC ACCATGCCCCACTGGGTGCGGGGGGCCCTTCTGGGCTGTGTGCCCCGGTGGCTTCTGATG AACCGGCCCCCACCACCCGTGGAGCTCTGCCACCCCCTACGCCTGAAGCTCAGCCCCTCT TATCACTGGCTGGAGAGCAACGTGGATGCCGAGGAGAGGGAGGTGGTGGTGGAGGAGGAG GACAGATGGGCATGTGCAGGTCATGTGGCCCCCTCTGTGGGCACCCTCTGCAGCCACGGC CACCTGCACTCTGGGGCCTCAGGTCCCAAGGCTGAGGCTCTGCTGCAGGAGGGTGAGCTG CTGCTATCACCCCACATGCAGAAGGCACTGGAAGGTGTGCACTACATTGCCGACCACCTG CGGTCTGAGGATGCTGACTCTTCGGTGAAGGAGGACTGGAAGTATGTTGCCATGGTCATC GACAGGATCTTCCTCTGGCTGTTTATCATCGTCTGCTTCCTGGGGACCATCGGCCTCTTT CTGCCTCCGTTCCTAGCTGGAATGATCTGA
pfams:PF02931Neur_chan_LBDPF02932Neur_chan_memb
go-classifiers:componentacetylcholine-gated channel complexcomponentcell junctioncomponentintegral component of membranecomponentneuron projectioncomponentplasma membranecomponentpostsynaptic membranecomponentsynapsefunctionacetylcholine bindingfunctionacetylcholine receptor activityfunctionacetylcholine-activated cation-selective channel activityfunctiondrug bindingprocesscation transmembrane transportprocession transportprocessneurological system processprocessneuromuscular synaptic transmissionprocessprotein heterooligomerizationprocessregulation of membrane potentialprocessresponse to nicotineprocesssignal transductionprocesssynaptic transmissionprocesssynaptic transmission, cholinergic

酶

载体

运输工具

药物反应

效应

不良反应